Please join us for our next seminar featuring Steven R. Duncan, MD, at 1 p.m. on Wednesday, August 16, in the HudsonAlpha auditorium. Duncan will present, “HLA-C AND KIR Interactions Influence the Risk for Chronic Obstructive Pulmonary Disease.”
Duncan’s medical school, internship, and residency training were at the University of Washington (Seattle), and he subsequently did fellowships in Critical Care at the University of Pittsburgh, Pulmonary Medicine at Stanford, and Molecular and Cellular Immunology at Scripps in La Jolla, CA. His lab’s research interests have lately focused on the immunopathogenesis of chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), two morbid and often fatal lung diseases that have distinct clinical phenotypes, but which share many similarly abnormal immunological features. Currently available therapeutics, based on nonspecific interventions, have meagre efficacy for these diseases. Their studies show adaptive immune processes are prominent in each, and pathogenic autoimmune responses in particular seem to be highly associated with clinical manifestations and progression of these syndromes. They are attempting to further test bench findings by moving to the beside with innovative clinical trials that specifically target autoimmune responses in these patients.
Greg Barsh, MD, PhD, will host the seminar.
More information on HudsonAlpha Research Seminars can be found at hudsonalpha.org/seminars.
